| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 3.8K |
| Sunitinib malate for the treatment of pancreatic neuroendocrine tumors | New England Journal of Medicine | 2011 | 1.8K |
| International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas | Pancreatology | 2012 | 1.7K |
| Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis | Gastroenterology | 2013 | 1.5K |
| Sampling variability of liver fibrosis in chronic hepatitis C | Hepatology | 2003 | 1.4K |
| A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis | Cancer | 1981 | 1.3K |
| TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system | Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin | 2006 | 1.2K |
| Clinical classification of pulmonary hypertension | Journal of the American College of Cardiology | 2004 | 1.2K |
| Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B | New England Journal of Medicine | 2003 | 1.1K |
| Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study | Lancet, The | 2013 | 1.1K |
| Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients | Gastroenterology | 1997 | 1.1K |
| Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C | Hepatology | 2005 | 1.1K |
| Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) | European Heart Journal | 2005 | 1.1K |
| Lanreotide in metastatic enteropancreatic neuroendocrine tumors | New England Journal of Medicine | 2014 | 1.1K |
| Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial | Lancet, The | 2017 | 999 |
| Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma | Nature Genetics | 2012 | 996 |
| Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B | New England Journal of Medicine | 2004 | 904 |
| Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B | New England Journal of Medicine | 2008 | 897 |
| Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection | Journal of the American College of Surgeons | 2000 | 884 |
| Mechanisms of hepatotoxicity | Toxicological Sciences | 2002 | 877 |
| Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets | Hepatology | 2007 | 805 |
| Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial | Journal of Clinical Oncology | 2005 | 780 |
| Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF) | Hepatology | 2000 | 765 |
| A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement | Journal of Hepatology | 2020 | 764 |
| Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection | New England Journal of Medicine | 2015 | 758 |
